Lower Respiratory Tract Infection
Lower Respiratory Tract Infection (LRTI) occurs when an infection, caused by a virus or bacteria, affects the lower airways of the lungs, presenting symptoms such as shortness of breath, fever, coughing, and fatigue. These infections may manifest as pneumonia, lung abscess, or acute bronchitis, and while a chest X-ray is not always necessary, LRTIs require medical attention for proper treatment and management.
Health Outcomes
- Accelerated Recovery of B Cell-Mediated Respiratory Immunity
- Adverse Safety Concern from Antimicrobial Resistance
- Decreased Lower Respiratory Quotient
- Elevated Antipneumococcal IgA Levels in Bronchoalveolar Lavage Fluid
- Elevated Viable Bacterial Counts
- Enhanced IgA Response
- Enhanced Immunity to Pneumococcal Infections
- Enhanced Non-specific Immune Defense
- Enhanced Pulmonary Immune Response
- Enhanced Respiratory Burst Activity
- Improved Airway Immune Response
- Improved Airway Secretion Clearance
- Improved Anti-infection Response
- Improved Antibiotic Resistance Outcomes
- Improved Bacterial Viability Under Stress
- Improved Disease Resolution
- Improved Health in Breastfed Infants
- Improved Lung Injury Outcomes
- Improved Resistance Against Respiratory Syncytial Virus
- Improved Resistance against Infections
- Improved Resistance to Pneumococcal Infection
- Improved Resistance to RSV Infection
- Improved Resistance to Secondary Pneumococcal Pneumonia
- Improved Respiratory Humoral Response
- Improved Respiratory Immunity
- Improved Respiratory Innate Immune Response
- Improved Respiratory Mucosal Barrier Function
- Improved Respiratory Tract Health
- Increased Antibody Levels for Avian Influenza Virus
- Increased Antigen-Specific Immunoglobulin A
- Increased Body Temperature
- Increased Days Alive and Out of Hospital
- Increased Days Without Illness
- Increased Fever
- Increased IL-8 Levels at 24 Hours
- Increased Infection
- Increased Post-Infection Lung Monocyte Levels
- Increased Resistance to Pneumococcal Infections
- Increased Respiratory Burst Activity
- Inhibited NI1060 in Pasteurella
- Modulated Pulmonary Innate Immune Microenvironment
- No Change in Blood-Culture Confirmed Sepsis
- No Reduction in Antibiotic Use
- No Significant Reduction in Lower Respiratory Tract Infections
- Preserved Anti-pseudomonal Activity
- Reduced Acute Respiratory Tract Infection Incidence
- Reduced Antibiotic Duration
- Reduced Antibiotic Usage
- Reduced Bacterial Infection Rates
- Reduced Clinical Sepsis
- Reduced Community-Acquired Infection
- Reduced Community-Acquired Infection Incidence
- Reduced Cough Duration
- Reduced Day Care Absence
- Reduced Day Care Absenteeism Due to Infections
- Reduced Duration of Common Cold Episodes
- Reduced Duration of Febrile Episodes
- Reduced Duration of Respiratory Infection
- Reduced Duration of Respiratory Tract Infection Episode
- Reduced Febrile Flares
- Reduced Fever
- Reduced Incidence of Influenza-like Illness
- Reduced Incidence of Respiratory Illness
- Reduced Infant Infections
- Reduced Infant Wheeze
- Reduced Infection Incidence
- Reduced Inflammation in the Lower Respiratory Tract
- Reduced Lower Respiratory Infection
- Reduced Lung Histopathology Scores
- Reduced Lung Viral Titers After Influenza
- Reduced Mean Number of Infections per Child
- Reduced Need for Intubation or Ventilation
- Reduced Nontransferable Antibiotic Resistance
- Reduced Oxygen Requirement
- Reduced Pathogen Growth
- Reduced Pathogen Incidence
- Reduced Postinfective Symptoms
- Reduced Pulmonary Free-CML
- Reduced RSV Replication
- Reduced RSV Titre in Lung
- Reduced RSV Viral Load in Lungs
- Reduced Respiratory Illness
- Reduced Respiratory Infections
- Reduced Respiratory Pathogen Load
- Reduced Respiratory Symptoms
- Reduced Respiratory Tract Infection
- Reduced Respiratory Tract Infection Episode
- Reduced Respiratory Tract Infection Episodes
- Reduced Risk of Prolonged Respiratory Infections
- Reduced Sepsis Incidence
- Reduced Sick Leave Days
- Reduced Susceptibility to Pneumococcal Infection
- Reduced Symptom Duration
- Reduced Time to Symptom Resolution
- Reduced Total Infections
- Reduced Tracheitis
- Reduced Viral Load in Epithelial Cells